Business Standard

Tuesday, December 24, 2024 | 08:20 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

Production of 1.35 bn vaccine doses between August, December a long haul

Covishield production to cross 120 mn doses a month, Covaxin 58 mn doses a month

Covaxin, Covishield, serum institute of india, bharat biotech, vaccine, vaccination, coronavirus, covid
Premium

According to Mandaviya’s statement in the Rajya Sabha, Covishield supplies would meet the target of 500 mn doses between August and December

Sohini Das Mumbai
Production of both Covishield and Covaxin – Covid-19 vaccines from Serum Institute of India (SII) and Bharat Biotech – is set to rise from next month. The target of 1.35 bn vaccine doses between August and December, however, looks like a long haul.

According to a response given in the Rajya Sabha, Health Minister Mansukh Mandaviya said recently that the monthly production capacity of Covishield is projected to increase from 110 mn doses to more than 120 mn doses a month, whereas the production capacity of Covaxin is projected to increase from 25 mn doses a month to around 58

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in